Skip to main content
Equibles
ANGO logo

ANGO · Angiodynamics Inc · Metrics

Track ANGO — free

Use ANGO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ANGO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$11.89 +0.08 (+0.68%)
Russell 2000 member Rebalance outlook locked
Market Cap
$500.45M
Shares
42.05M
Volume · Oct 21 725.31K Avg daily vol (3M) 624.06K

ANGO metrics

91 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$11.89
Market cap
$500.45M

Price action

20 metrics
Price change (1W)
+8.3%
Price change (30D)
-23.4%
Price change (3M)
-16.9%
Price change (6M)
+10.2%
Price change (YTD)
-8.0%
Price change (1Y)
-0.1%
Trailing year
Price change (5Y)
-58.4%
52-week high
$16.13
52-week low
$9.70
Change from 52-week high
-26.8%
Change from 52-week low
+21.8%
Annualized volatility
48.0%
Annualized volatility (3M)
52.5%
Beta
1.0
RSI (14D)
34.4
Price vs SMA 50
-20.0%
Price vs SMA 200
-4.9%
Avg volume (3M)
622,166
Relative volume
2.2
Average dollar volume
$8.66M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
42.05M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.5×
reciprocal yield 65.7%
P / book
3.0
reciprocal yield 33.1%
FCF yield
0.3%
TTM · current market cap
Buyback yield
0.0%
P / FCF
343.1
reciprocal yield 0.3%
P / operating cash flow
134.9
reciprocal yield 0.7%
Earnings yield
-6.6%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.1×
reciprocal yield 87.4%
EV / revenue historical average (5Y)
1.1×
reciprocal yield 88.2%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
16.1×
reciprocal yield 6.2%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-08

Profitability

9 metrics
Gross margin
55.7%
Operating margin
-11.2%
Trailing 12 months
Net margin
-10.1%
Gross profit (TTM)
$181.07M
Operating profit (TTM)
−$36.57M
Net income (TTM)
−$32.94M
Trailing 12 months
Diluted EPS (TTM)
$-0.79
FCF margin
0.4%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$7.80
Gross profit per diluted share (TTM)
$4.34
Operating profit per diluted share (TTM)
$-0.88
EBITDA per diluted share (TTM)
$-0.34
Net income per diluted share (TTM)
$-0.79
Operating cash flow per diluted share (TTM)
$0.09
Free cash flow per diluted share (TTM)
$0.04
Capital expenditures per diluted share (TTM)
$0.05
R&D per diluted share (TTM)
$0.74
Stock compensation per diluted share (TTM)
$0.33
Book value per share
$4.10

Growth

11 metrics
Revenue growth YoY
+6.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$325.38M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.1%
Year over year · more shares
Revenue CAGR (3Y)
-1.9%
Revenue CAGR (5Y)
+1.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
-51.5%

Quality

14 metrics
Return on equity
-20.1%
Return on assets
-13.6%
Debt / equity
—
Current ratio
2.4
EBITDA (TTM)
−$14.07M
Free cash flow (TTM)
$1.44M
Quick ratio
1.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$33.97M
Total assets
$241.93M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$3.67M
Capital expenditures (TTM)
$2.23M
R&D (TTM)
$31.01M
SG&A (TTM)
—
Stock compensation (TTM)
$13.99M
R&D / revenue
9.5%
Stock compensation / revenue
4.3%

Ownership (13F)

9 metrics
13F filers
161
13F filer change QoQ
+14
Institutional ownership
90.3%
Conviction holders (share of 13F filers)
1.9%
Crowding (high-turnover and private-fund holders)
46.7%
Private-fund adviser ownership
44.1%
Active holders' share change QoQ
-0.5%
Holder tenure
12.7
Price vs estimated holder cost
+31.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
13.2%

Short interest

3 metrics
Short interest
3.1%
Latest settlement · 2.2 days to cover
Days to cover
2.2d
Short-squeeze score
41 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$344,006
Insider-sentiment score
38 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1275187 CUSIP 03475V101 13F (30d) 18 filings 18 filers Visit website Investor relations